Proton beam radiation for kidney cancer

This trial tests whether targeted external-beam radiation (SBRT) can control a small number of progressing kidney cancer spots while you continue immune checkpoint inhibitor immunotherapy. It may help shrink or stop those specific “oligoprogressive” lesions and prolong benefit from your current immunotherapy.

This study is testing whether high-dose radiation therapy can safely treat kidney cancer that has spread to a few spots in the body, either when it is first found or when it grows during standard drug treatment. The goal is to see if this approach is effective and well-tolerated.

This trial studies how well people do—especially their quality of life—after SBRT radiation for primary kidney cancer that can’t be removed with surgery. It may help doctors understand which patients benefit most and what side effects to expect.

This early study tests a type of radiation delivery (“pencil beam scanning”) for certain kidney cancers in children and teens. It may help doctors better target the tumor while reducing radiation to nearby healthy tissue.

This trial uses a precise, high-dose radiation technique (called stereotactic body radiation therapy) that tracks and treats kidney tumors while you breathe. It aims to destroy tumors without surgery, potentially offering a less invasive option for people who cannot or prefer not to have an operation.

This trial tests a precise type of radiation therapy for small, early-stage kidney tumors that cannot be surgically removed or are at high risk for surgery. It aims to offer an alternative treatment with fewer side effects.